HEADER STRUCTURAL PROTEIN 27-OCT-18 6I17 TITLE CRYSTAL STRUCTURE OF FASCIN IN COMPLEX WITH COMPOUND 24 COMPND MOL_ID: 1; COMPND 2 MOLECULE: FASCIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: 55 KDA ACTIN-BUNDLING PROTEIN,SINGED-LIKE PROTEIN,P55; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FSCN1, FAN1, HSN, SNL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PBDDP-SPR3 KEYWDS ACTIN BUNDLING, SMALL MOLECULE INHIBITION, STRUCTURAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.W.SCHUETTELKOPF REVDAT 3 24-JAN-24 6I17 1 REMARK REVDAT 2 20-MAR-19 6I17 1 JRNL REVDAT 1 27-FEB-19 6I17 0 JRNL AUTH S.FRANCIS,D.CROFT,A.W.SCHUTTELKOPF,C.PARRY,A.PUGLIESE, JRNL AUTH 2 K.CAMERON,S.CLAYDON,M.DRYSDALE,C.GARDNER,A.GOHLKE,G.GOODWIN, JRNL AUTH 3 C.H.GRAY,J.KONCZAL,L.MCDONALD,M.MEZNA,A.PANNIFER,N.R.PAUL, JRNL AUTH 4 L.MACHESKY,H.MCKINNON,J.BOWER JRNL TITL STRUCTURE-BASED DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION JRNL TITL 2 OF A NOVEL SERIES OF ISOQUINOLONE AND JRNL TITL 3 PYRAZOLO[4,3-C]PYRIDINE INHIBITORS OF FASCIN 1 AS POTENTIAL JRNL TITL 4 ANTI-METASTATIC AGENTS. JRNL REF BIOORG.MED.CHEM.LETT. V. 29 1023 2019 JRNL REFN ESSN 1464-3405 JRNL PMID 30773430 JRNL DOI 10.1016/J.BMCL.2019.01.035 REMARK 2 REMARK 2 RESOLUTION. 1.56 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0222 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.56 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 65.18 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 70088 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3691 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.56 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.60 REMARK 3 REFLECTION IN BIN (WORKING SET) : 5082 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.40 REMARK 3 BIN R VALUE (WORKING SET) : 0.3870 REMARK 3 BIN FREE R VALUE SET COUNT : 259 REMARK 3 BIN FREE R VALUE : 0.3620 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3784 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 43 REMARK 3 SOLVENT ATOMS : 411 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.87 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.23 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.13000 REMARK 3 B22 (A**2) : 0.24000 REMARK 3 B33 (A**2) : -0.37000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.093 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.094 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.086 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.930 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.941 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3951 ; 0.016 ; 0.014 REMARK 3 BOND LENGTHS OTHERS (A): 3432 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5352 ; 1.727 ; 1.671 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8054 ; 1.631 ; 1.659 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 493 ; 5.414 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 222 ;30.203 ;21.396 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 646 ;12.552 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 33 ;13.035 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 502 ; 0.104 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4566 ; 0.010 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 774 ; 0.013 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1961 ; 0.771 ; 1.168 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1959 ; 0.771 ; 1.168 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2457 ; 1.213 ; 1.749 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 5 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 10 A 138 REMARK 3 ORIGIN FOR THE GROUP (A): 4.8830 8.6590 -7.5800 REMARK 3 T TENSOR REMARK 3 T11: 0.0226 T22: 0.0402 REMARK 3 T33: 0.0329 T12: -0.0014 REMARK 3 T13: 0.0026 T23: -0.0081 REMARK 3 L TENSOR REMARK 3 L11: 2.4592 L22: 2.0358 REMARK 3 L33: 1.9783 L12: -0.3206 REMARK 3 L13: 0.7979 L23: -0.0394 REMARK 3 S TENSOR REMARK 3 S11: -0.0179 S12: 0.0618 S13: -0.0054 REMARK 3 S21: -0.0392 S22: 0.0091 S23: -0.2322 REMARK 3 S31: 0.0876 S32: 0.1789 S33: 0.0088 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 139 A 260 REMARK 3 ORIGIN FOR THE GROUP (A): -13.6080 -3.5540 -23.6180 REMARK 3 T TENSOR REMARK 3 T11: 0.1002 T22: 0.0216 REMARK 3 T33: 0.0563 T12: 0.0047 REMARK 3 T13: -0.0326 T23: -0.0291 REMARK 3 L TENSOR REMARK 3 L11: 2.1999 L22: 1.7907 REMARK 3 L33: 2.9313 L12: 0.1735 REMARK 3 L13: 0.8306 L23: -0.1081 REMARK 3 S TENSOR REMARK 3 S11: 0.1426 S12: 0.0991 S13: -0.2716 REMARK 3 S21: -0.0634 S22: 0.0176 S23: -0.0384 REMARK 3 S31: 0.3796 S32: 0.0928 S33: -0.1602 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 261 A 384 REMARK 3 ORIGIN FOR THE GROUP (A): -21.8910 19.7740 -43.7420 REMARK 3 T TENSOR REMARK 3 T11: 0.1910 T22: 0.0949 REMARK 3 T33: 0.0708 T12: -0.0123 REMARK 3 T13: -0.0010 T23: 0.0096 REMARK 3 L TENSOR REMARK 3 L11: 0.7426 L22: 2.6180 REMARK 3 L33: 3.0909 L12: -0.0772 REMARK 3 L13: -0.5992 L23: 0.1739 REMARK 3 S TENSOR REMARK 3 S11: 0.0612 S12: 0.1927 S13: 0.0802 REMARK 3 S21: -0.4591 S22: 0.0680 S23: 0.0464 REMARK 3 S31: -0.3721 S32: -0.1227 S33: -0.1292 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 385 A 493 REMARK 3 ORIGIN FOR THE GROUP (A): -23.8290 20.9950 -17.8370 REMARK 3 T TENSOR REMARK 3 T11: 0.0172 T22: 0.0174 REMARK 3 T33: 0.0531 T12: 0.0070 REMARK 3 T13: 0.0147 T23: -0.0006 REMARK 3 L TENSOR REMARK 3 L11: 1.6914 L22: 1.8598 REMARK 3 L33: 3.5427 L12: -0.6561 REMARK 3 L13: 0.7685 L23: 0.3756 REMARK 3 S TENSOR REMARK 3 S11: 0.0202 S12: -0.0131 S13: 0.1938 REMARK 3 S21: -0.0100 S22: 0.0217 S23: 0.0663 REMARK 3 S31: -0.1785 S32: -0.1219 S33: -0.0419 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 3 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 503 A 503 REMARK 3 RESIDUE RANGE : A 601 A 1011 REMARK 3 RESIDUE RANGE : A 501 A 502 REMARK 3 ORIGIN FOR THE GROUP (A): -12.2170 11.2540 -18.8930 REMARK 3 T TENSOR REMARK 3 T11: 0.1358 T22: 0.1239 REMARK 3 T33: 0.1265 T12: -0.0193 REMARK 3 T13: 0.0174 T23: -0.0153 REMARK 3 L TENSOR REMARK 3 L11: 0.7505 L22: 0.5640 REMARK 3 L33: 1.0604 L12: -0.1358 REMARK 3 L13: 0.5487 L23: -0.1114 REMARK 3 S TENSOR REMARK 3 S11: 0.0064 S12: 0.0116 S13: 0.0113 REMARK 3 S21: -0.0295 S22: 0.0214 S23: 0.0196 REMARK 3 S31: 0.0146 S32: -0.0519 S33: -0.0278 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: U VALUES : WITH TLS ADDED HYDROGENS REMARK 3 HAVE BEEN ADDED IN THE RIDING POSITIONS REMARK 4 REMARK 4 6I17 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-OCT-18. REMARK 100 THE DEPOSITION ID IS D_1200012640. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-APR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 0.4.0.291 REMARK 200 DATA SCALING SOFTWARE : XIA2 0.4.0.291 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 74348 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.560 REMARK 200 RESOLUTION RANGE LOW (A) : 97.970 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : 0.06900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.56 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.60 REMARK 200 R MERGE FOR SHELL (I) : 1.28100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 6I10 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18-22% PEG 8000, 100-130 MM MGAC2, 100 REMARK 280 MM CITRIC ACID PH 5.0, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 30.22200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.98600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.55350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.98600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.22200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.55350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 460 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21070 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 THR A 2 REMARK 465 ALA A 3 REMARK 465 ASN A 4 REMARK 465 GLY A 5 REMARK 465 THR A 6 REMARK 465 ALA A 7 REMARK 465 GLU A 8 REMARK 465 ALA A 9 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG A 158 CD NE CZ NH1 NH2 REMARK 480 ARG A 205 NE CZ NH1 NH2 REMARK 480 LYS A 244 CG CD CE NZ REMARK 480 ASP A 286 CG OD1 OD2 REMARK 480 ARG A 300 CD NE CZ NH1 NH2 REMARK 480 LYS A 359 CD CE NZ REMARK 480 LYS A 399 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 288 CD GLU A 288 OE1 -0.070 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 41 -165.63 -115.21 REMARK 500 GLU A 116 -129.18 48.25 REMARK 500 ASP A 166 11.54 -149.91 REMARK 500 ASP A 183 -121.60 60.09 REMARK 500 THR A 239 118.13 -33.98 REMARK 500 SER A 325 58.97 -92.58 REMARK 500 ARG A 341 78.50 -118.37 REMARK 500 ASP A 342 -115.33 64.44 REMARK 500 VAL A 400 -60.82 73.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GZW A 503 DBREF 6I17 A 1 493 UNP Q16658 FSCN1_HUMAN 1 493 SEQRES 1 A 493 MET THR ALA ASN GLY THR ALA GLU ALA VAL GLN ILE GLN SEQRES 2 A 493 PHE GLY LEU ILE ASN CYS GLY ASN LYS TYR LEU THR ALA SEQRES 3 A 493 GLU ALA PHE GLY PHE LYS VAL ASN ALA SER ALA SER SER SEQRES 4 A 493 LEU LYS LYS LYS GLN ILE TRP THR LEU GLU GLN PRO PRO SEQRES 5 A 493 ASP GLU ALA GLY SER ALA ALA VAL CYS LEU ARG SER HIS SEQRES 6 A 493 LEU GLY ARG TYR LEU ALA ALA ASP LYS ASP GLY ASN VAL SEQRES 7 A 493 THR CYS GLU ARG GLU VAL PRO GLY PRO ASP CYS ARG PHE SEQRES 8 A 493 LEU ILE VAL ALA HIS ASP ASP GLY ARG TRP SER LEU GLN SEQRES 9 A 493 SER GLU ALA HIS ARG ARG TYR PHE GLY GLY THR GLU ASP SEQRES 10 A 493 ARG LEU SER CYS PHE ALA GLN THR VAL SER PRO ALA GLU SEQRES 11 A 493 LYS TRP SER VAL HIS ILE ALA MET HIS PRO GLN VAL ASN SEQRES 12 A 493 ILE TYR SER VAL THR ARG LYS ARG TYR ALA HIS LEU SER SEQRES 13 A 493 ALA ARG PRO ALA ASP GLU ILE ALA VAL ASP ARG ASP VAL SEQRES 14 A 493 PRO TRP GLY VAL ASP SER LEU ILE THR LEU ALA PHE GLN SEQRES 15 A 493 ASP GLN ARG TYR SER VAL GLN THR ALA ASP HIS ARG PHE SEQRES 16 A 493 LEU ARG HIS ASP GLY ARG LEU VAL ALA ARG PRO GLU PRO SEQRES 17 A 493 ALA THR GLY TYR THR LEU GLU PHE ARG SER GLY LYS VAL SEQRES 18 A 493 ALA PHE ARG ASP CYS GLU GLY ARG TYR LEU ALA PRO SER SEQRES 19 A 493 GLY PRO SER GLY THR LEU LYS ALA GLY LYS ALA THR LYS SEQRES 20 A 493 VAL GLY LYS ASP GLU LEU PHE ALA LEU GLU GLN SER CYS SEQRES 21 A 493 ALA GLN VAL VAL LEU GLN ALA ALA ASN GLU ARG ASN VAL SEQRES 22 A 493 SER THR ARG GLN GLY MET ASP LEU SER ALA ASN GLN ASP SEQRES 23 A 493 GLU GLU THR ASP GLN GLU THR PHE GLN LEU GLU ILE ASP SEQRES 24 A 493 ARG ASP THR LYS LYS CYS ALA PHE ARG THR HIS THR GLY SEQRES 25 A 493 LYS TYR TRP THR LEU THR ALA THR GLY GLY VAL GLN SER SEQRES 26 A 493 THR ALA SER SER LYS ASN ALA SER CYS TYR PHE ASP ILE SEQRES 27 A 493 GLU TRP ARG ASP ARG ARG ILE THR LEU ARG ALA SER ASN SEQRES 28 A 493 GLY LYS PHE VAL THR SER LYS LYS ASN GLY GLN LEU ALA SEQRES 29 A 493 ALA SER VAL GLU THR ALA GLY ASP SER GLU LEU PHE LEU SEQRES 30 A 493 MET LYS LEU ILE ASN ARG PRO ILE ILE VAL PHE ARG GLY SEQRES 31 A 493 GLU HIS GLY PHE ILE GLY CYS ARG LYS VAL THR GLY THR SEQRES 32 A 493 LEU ASP ALA ASN ARG SER SER TYR ASP VAL PHE GLN LEU SEQRES 33 A 493 GLU PHE ASN ASP GLY ALA TYR ASN ILE LYS ASP SER THR SEQRES 34 A 493 GLY LYS TYR TRP THR VAL GLY SER ASP SER ALA VAL THR SEQRES 35 A 493 SER SER GLY ASP THR PRO VAL ASP PHE PHE PHE GLU PHE SEQRES 36 A 493 CYS ASP TYR ASN LYS VAL ALA ILE LYS VAL GLY GLY ARG SEQRES 37 A 493 TYR LEU LYS GLY ASP HIS ALA GLY VAL LEU LYS ALA SER SEQRES 38 A 493 ALA GLU THR VAL ASP PRO ALA SER LEU TRP GLU TYR HET ACT A 501 4 HET EDO A 502 4 HET GZW A 503 35 HETNAM ACT ACETATE ION HETNAM EDO 1,2-ETHANEDIOL HETNAM GZW 2-[(3,4-DICHLOROPHENYL)METHYL]-~{N}-(1-METHYLPYRAZOL-4- HETNAM 2 GZW YL)-1-OXIDANYLIDENE-6-PIPERIDIN-4-YL-2,7- HETNAM 3 GZW NAPHTHYRIDINE-4-CARBOXAMIDE HETSYN EDO ETHYLENE GLYCOL FORMUL 2 ACT C2 H3 O2 1- FORMUL 3 EDO C2 H6 O2 FORMUL 4 GZW C25 H24 CL2 N6 O2 FORMUL 5 HOH *411(H2 O) HELIX 1 AA1 LYS A 41 GLN A 44 5 4 HELIX 2 AA2 GLY A 86 CYS A 89 5 4 HELIX 3 AA3 SER A 127 LYS A 131 5 5 HELIX 4 AA4 GLY A 172 LEU A 176 5 5 HELIX 5 AA5 GLU A 207 GLY A 211 5 5 HELIX 6 AA6 GLY A 249 GLU A 252 5 4 HELIX 7 AA7 THR A 289 THR A 293 5 5 HELIX 8 AA8 ASN A 331 TYR A 335 5 5 HELIX 9 AA9 GLY A 371 LEU A 375 5 5 HELIX 10 AB1 ASP A 486 LEU A 490 5 5 SHEET 1 AA1 2 PHE A 14 ILE A 17 0 SHEET 2 AA1 2 SER A 133 ILE A 136 -1 O HIS A 135 N GLY A 15 SHEET 1 AA2 2 TYR A 23 ALA A 26 0 SHEET 2 AA2 2 VAL A 33 ALA A 37 -1 O ASN A 34 N THR A 25 SHEET 1 AA3 2 TRP A 46 GLU A 49 0 SHEET 2 AA3 2 CYS A 61 SER A 64 -1 O ARG A 63 N THR A 47 SHEET 1 AA4 2 TYR A 69 ALA A 72 0 SHEET 2 AA4 2 VAL A 78 ARG A 82 -1 O ARG A 82 N TYR A 69 SHEET 1 AA5 2 PHE A 91 ALA A 95 0 SHEET 2 AA5 2 TRP A 101 SER A 105 -1 O GLN A 104 N LEU A 92 SHEET 1 AA6 2 TYR A 111 GLY A 113 0 SHEET 2 AA6 2 SER A 120 ALA A 123 -1 O SER A 120 N GLY A 113 SHEET 1 AA7 4 ILE A 163 ARG A 167 0 SHEET 2 AA7 4 ARG A 151 LEU A 155 -1 N TYR A 152 O ARG A 167 SHEET 3 AA7 4 GLN A 141 SER A 146 -1 N ILE A 144 O ALA A 153 SHEET 4 AA7 4 ILE A 177 THR A 178 -1 O ILE A 177 N VAL A 142 SHEET 1 AA8 4 ILE A 163 ARG A 167 0 SHEET 2 AA8 4 ARG A 151 LEU A 155 -1 N TYR A 152 O ARG A 167 SHEET 3 AA8 4 GLN A 141 SER A 146 -1 N ILE A 144 O ALA A 153 SHEET 4 AA8 4 PHE A 254 GLN A 258 -1 O ALA A 255 N TYR A 145 SHEET 1 AA9 2 PHE A 181 GLN A 182 0 SHEET 2 AA9 2 ARG A 185 TYR A 186 -1 O ARG A 185 N GLN A 182 SHEET 1 AB1 2 PHE A 195 LEU A 196 0 SHEET 2 AB1 2 LEU A 202 VAL A 203 -1 O VAL A 203 N PHE A 195 SHEET 1 AB2 2 THR A 213 ARG A 217 0 SHEET 2 AB2 2 LYS A 220 ARG A 224 -1 O ARG A 224 N THR A 213 SHEET 1 AB3 2 LEU A 231 SER A 234 0 SHEET 2 AB3 2 THR A 239 ALA A 242 -1 O LYS A 241 N ALA A 232 SHEET 1 AB4 4 CYS A 305 ARG A 308 0 SHEET 2 AB4 4 PHE A 294 ILE A 298 -1 N GLU A 297 O ALA A 306 SHEET 3 AB4 4 GLN A 262 GLN A 266 -1 N VAL A 263 O PHE A 294 SHEET 4 AB4 4 LEU A 377 LEU A 380 -1 O LEU A 377 N GLN A 266 SHEET 1 AB5 2 ASN A 272 SER A 274 0 SHEET 2 AB5 2 SER A 282 GLN A 285 -1 O GLN A 285 N ASN A 272 SHEET 1 AB6 2 TYR A 314 LEU A 317 0 SHEET 2 AB6 2 VAL A 323 ALA A 327 -1 O GLN A 324 N THR A 316 SHEET 1 AB7 2 ASP A 337 ARG A 341 0 SHEET 2 AB7 2 ARG A 344 ARG A 348 -1 O ARG A 348 N ASP A 337 SHEET 1 AB8 2 PHE A 354 SER A 357 0 SHEET 2 AB8 2 LEU A 363 VAL A 367 -1 O VAL A 367 N PHE A 354 SHEET 1 AB9 3 ILE A 385 ILE A 386 0 SHEET 2 AB9 3 PHE A 414 ASN A 419 -1 O PHE A 414 N ILE A 386 SHEET 3 AB9 3 ALA A 422 LYS A 426 -1 O LYS A 426 N GLN A 415 SHEET 1 AC1 3 ARG A 389 GLY A 390 0 SHEET 2 AC1 3 GLY A 393 CYS A 397 -1 O GLY A 393 N GLY A 390 SHEET 3 AC1 3 LEU A 404 ARG A 408 -1 O ARG A 408 N PHE A 394 SHEET 1 AC2 2 TYR A 432 VAL A 435 0 SHEET 2 AC2 2 VAL A 441 GLY A 445 -1 O GLY A 445 N TYR A 432 SHEET 1 AC3 4 PHE A 452 ASP A 457 0 SHEET 2 AC3 4 LYS A 460 VAL A 465 -1 O LYS A 464 N PHE A 452 SHEET 3 AC3 4 ARG A 468 GLY A 472 -1 O ARG A 468 N VAL A 465 SHEET 4 AC3 4 LEU A 478 ALA A 482 -1 O ALA A 482 N TYR A 469 SHEET 1 AC4 3 PHE A 452 ASP A 457 0 SHEET 2 AC4 3 LYS A 460 VAL A 465 -1 O LYS A 464 N PHE A 452 SHEET 3 AC4 3 TRP A 491 GLU A 492 -1 O TRP A 491 N VAL A 461 CISPEP 1 ARG A 158 PRO A 159 0 11.08 SITE 1 AC1 5 TRP A 101 VAL A 134 THR A 213 LEU A 214 SITE 2 AC1 5 HOH A 657 SITE 1 AC2 4 ASN A 18 ARG A 100 SER A 133 HOH A 649 SITE 1 AC3 16 LEU A 48 ALA A 58 ILE A 93 ALA A 95 SITE 2 AC3 16 TRP A 101 VAL A 134 LEU A 214 GLU A 215 SITE 3 AC3 16 PHE A 216 ARG A 217 ARG A 224 GLN A 277 SITE 4 AC3 16 HOH A 699 HOH A 857 HOH A 895 HOH A 944 CRYST1 60.444 87.107 97.972 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016544 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011480 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010207 0.00000